ConductScience.org, home

Paper28244635

Effect of linagliptin on pulse wave velocity in early type 2 diabetes: A randomized, double-blind, controlled 26-week trial (RELEASE).

de Boer SA and 8 others. Diabetes Obes Metab, 2017. Cited by 41 papers, by iCite.

Cite this record

ConductScience Library. Effect of linagliptin on pulse wave velocity in early type 2 diabetes: A randomized, double-blind, controlled 26-week trial (RELEASE). Papers, record 28244635. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28244635

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of linagliptin on pulse wave velocity in early type 2 diabetes: A randomized, double-blind, controlled 26-week trial (RELEASE).
PubMed
Journal
Diabetes Obes Metab
PubMed
Year
2017
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
41
iCite
Relative citation ratio, by iCite
1.77
iCite
Revised in PubMed
2026-01-27
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1de Boer SAStefanie Ahttps://orcid.org/0000-0002-7532-2536
2Heerspink HJLHiddo J Lhttps://orcid.org/0000-0002-3126-3730
3Juárez Orozco LELuis E
4van Roon AMArie M
5Kamphuisen PWPieter W
6Smit AJAndries J
7Slart RHJARiemer H J A
8Lefrandt JDJoop D
9Mulder DJDouwe J

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AtherosclerosisMajor topic
Diabetes Mellitus, Type 2Major topic
Diabetic AngiopathiesMajor topic
Dipeptidyl-Peptidase IV InhibitorsMajor topic
HyperglycemiaMajor topic
LinagliptinMajor topic
Vascular StiffnessMajor topic
Aorta
Biomarkers
Blood Pressure
Double-Blind Method
Female
Follow-Up Studies
Glycated Hemoglobin
Humans
Hypertension
Hypertriglyceridemia
Hypoglycemia
Male
Middle Aged
Pulse Wave Analysis
Severity of Illness Index

Source PubMed

Download CSV of topics

Cited by34

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.

PMIDTitleJournalYearIn PapersSource
42454434Efficacy of DPP-4 Inhibitors on Seated and Ambulatory Blood Pressure in Type 2 Diabetes Mellitus.Diabetes Obes Metab2026https://conductscience.org/library/papers/42454434PubMed
42453632Large-Scale Protein Assay Identifies Novel Protein Biomarkers Associated With Arterial Stiffness and Vascular Calcification Measures.Int J Hypertens2026https://conductscience.org/library/papers/42453632PubMed
41639755A cross-sectional study: carotid artery stiffness in individuals with varying cardiovascular disease risk using shear wave elasticity.BMC Cardiovasc Disord2026https://conductscience.org/library/papers/41639755PubMed
41280329Role of obesity in chronic kidney disease progression.Curr Res Physiol2025https://conductscience.org/library/papers/41280329PubMed
41204172EVATRAN (The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients): study protocol for a cross-over randomized controlled trial.Trials2025https://conductscience.org/library/papers/41204172PubMed
40244362The impact of DPP-4 inhibitors on cardiovascular disease treatment: a comprehensive review of current therapeutic strategies and future directions.Mol Biol Rep2025https://conductscience.org/library/papers/40244362PubMed
40149869Inhibition of DPP-4 Attenuates Endotoxemia-Induced NLRC4 Inflammasome and Inflammation in Visceral Adipose Tissue of Mice Fed a High-Fat Diet.Biomolecules2025https://conductscience.org/library/papers/40149869PubMed
38981645Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaboration.BMJ2024https://conductscience.org/library/papers/38981645PubMed
37493797Dipeptidyl-peptidase-4 inhibitors have anti-inflammatory effects in patients with type 2 diabetes.Eur J Clin Pharmacol2023https://conductscience.org/library/papers/37493797PubMed
37175496An Overview of the Cardioprotective Effects of Novel Antidiabetic Classes: Focus on Inflammation, Oxidative Stress, and Fibrosis.Int J Mol Sci2023https://conductscience.org/library/papers/37175496PubMed
37165762Effects of first-line antidiabetic drugs on the improvement of arterial stiffness: A Bayesian network meta-analysis.J Diabetes2023https://conductscience.org/library/papers/37165762PubMed
35986429DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits.Mil Med Res2022https://conductscience.org/library/papers/35986429PubMed
35923194Comparative analysis of the efficacies of probiotic supplementation and glucose-lowering drugs for the treatment of type 2 diabetes: A systematic review and meta-analysis.Front Nutr2022https://conductscience.org/library/papers/35923194PubMed
34888012Effect of glycemic control on markers of subclinical atherosclerosis in patients with type 2 diabetes mellitus: A review.World J Diabetes2021https://conductscience.org/library/papers/34888012PubMed
34679685
Plasma Nitrate Levels Are Related to Metabolic Syndrome and Are Not Altered by Treatment with DPP-4 Inhibitor Linagliptin: A Randomised, Placebo-Controlled Trial in Patients with Early Type 2 Diabetes Mellitus.
Antioxidants (Basel)2021https://conductscience.org/library/papers/34679685PubMed
34489872Roles and Mechanisms of Dipeptidyl Peptidase 4 Inhibitors in Vascular Aging.Front Endocrinol (Lausanne)2021https://conductscience.org/library/papers/34489872PubMed
33570554DPP4 Activity, Hyperinsulinemia, and Atherosclerosis.J Clin Endocrinol Metab2021https://conductscience.org/library/papers/33570554PubMed
33397376Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial.Cardiovasc Diabetol2021https://conductscience.org/library/papers/33397376PubMed
32900588Anti-inflammatory properties of antidiabetic drugs: A "promised land" in the COVID-19 era?J Diabetes Complications2020https://conductscience.org/library/papers/32900588PubMed
32886301[18F]FDG Uptake in Adipose Tissue Is Not Related to Inflammation in Type 2 Diabetes Mellitus.Mol Imaging Biol2021https://conductscience.org/library/papers/32886301PubMed

See all 34 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
DPP41803PubTator's text mininghttps://conductscience.org/library/genes/1803

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28244635

GET https://conductscience.org/api/papers/v1/28244635/cited_by?page=2